The Orphan Drug Backlash

The Orphan Drug Act of 1983 was supposed to provide incentives for private industry to develop needed, but unprofitable, drugs to treat rare diseases. It has done so, but not without eliciting controversy

By Thomas Maeder on May 1, 2003

Visit our Librarian Gateway for additional information on purchasing a site license to this and other products